Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
December 13, 2021
Tickers
ALXO
From Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
December 13, 2021
Tickers
VIRX
From Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
December 13, 2021
Tickers
HARP
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
From Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
December 13, 2021
Tickers
JAZZ
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
From Benzinga
From Benzinga
From Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
December 10, 2021
From Benzinga
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
December 10, 2021
Tickers
ANGN
From Benzinga
Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
December 09, 2021
From Benzinga
Ideaya Reports New Data From Combo Therapy Regime In Pretreated Eye Cancer Patients
December 07, 2021
Tickers
IDYA
From Benzinga
Prometheus Biosciences Posts Phase 1 Data On Lead Therapeutic Candidate
December 07, 2021
Tickers
RXDX
From Benzinga
Bellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
December 06, 2021
Tickers
BLCM
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
December 06, 2021
Tickers
OCUL
From Benzinga
GH Research Posts Data From Treatment-Resistant Depression Trial
December 06, 2021
Tickers
GHRS
From Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
December 06, 2021
Tickers
MOLN
From Benzinga
Kazia Unveils Final Data From Mid-Stage Paxalisib Data In Newly Diagnosed Glioblastoma Patients
December 03, 2021
Tickers
KZIA
From Benzinga
Xenon Stock Jumps On New Encouraging Data From Epilepsy Treatment
December 03, 2021
Tickers
XENE
From Benzinga
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
December 02, 2021
Tickers
SQZ
From Benzinga
VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial
December 02, 2021
From Benzinga
Inhibrx Precision Cancer Antibody Receives FDA Orphan Drug Tag For Rare Bone Cancer
December 02, 2021
Tickers
INBX
From Benzinga
Clene's Amyotrophic Lateral Sclerosis Candidate Shows Favorable Impact On Disease Progression
December 01, 2021
Tickers
CLNN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.